Portfolio company
Curevo Vaccine
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This clinical-stage biotechnology company develops next-generation subunit vaccines for shingles and chickenpox to serve adults and immunocompromised patients.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Curevo
This clinical-stage biotechnology company develops non-mRNA subunit vaccines to prevent shingles and chickenpox in adults and children.
Simplexia
This company develops a vaccine against herpes simplex virus type 2 for patients with genital herpes infections.
Nykode Therapeutics
This company develops immunotherapy vaccines to treat patients with cancer and autoimmune diseases.
Centivax
This company develops broad-spectrum vaccines and monoclonal antibodies using computational immune engineering to protect against infectious diseases and pathogens for global healthcare systems.
CureAge
This company develops curative gene therapies for patients with neurofibromatosis type 1 and other peripheral nerve diseases using lipid nanoparticle technology.
Revealis Biotherapeutics
This company develops therapeutic cancer vaccines targeting immune-escaped and immunotherapy-resistant tumours for healthcare providers and patients.
Jurata
This company develops thermostable thin-film formulations for vaccines and biologics, enabling needle-free administration and room-temperature storage for pharmaceutical manufacturers and healthcare providers.
Vaccitech Ltd
This biopharmaceutical company develops immunotherapeutic products and vaccines for patients with chronic infectious diseases, autoimmune conditions and cancer.
